Larvol Delta - First-Patient-Dosed-in-Phase-II-Trial-to-Treat-Complications-in-COVID19

MetaBlok (lsalt peptide) - Arch Biopartners

http://www.globenewswire.com/news-release/2020/10/16/2109778/0/en/First-Patient-Dosed-in-Phase-II-Trial-to-Treat-Complications-in-COVID-19.html

Oct 16, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next